Last reviewed · How we verify

NCT03887767

sST2 and Cardiac Surgery

Completed Last updated 10 March 2020
What this trial tests

trial in Cardiac Surgery in 158 participants. Completed in 20 December 2019.

Timeline
25 March 2019
Primary endpoint
1 December 2019
20 December 2019

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment158
Start date25 March 2019
Primary completion1 December 2019
Estimated completion20 December 2019
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 80, any sex, with Cardiac Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery. The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiac Surgery

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03887767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing